Advaxis, Inc. Made Headway

Mon, Feb 10, 2020 at 05:41 PM

Advaxis, Inc. (ADXS:NASDAQ) soared at $1.07, representing a gain of 28.7%. The stock got featured on our News Catalysts scanner on Thu 30 Jan 20 at 10:31 AM in the 'BIOTECH' category. From Fri 17 Jan 20, the stock recorded 14.29% Up Days and 20.00% Green Days

The stock spiked on Tue 07 Jan 20 at $1.48 with a volume of 39M+.

About Advaxis, Inc. (ADXS:NASDAQ)

Advaxis Inc focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies.

Top 10 Gainers:

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 1335.24%
Precigen, Inc. (XON:NYSE), 293.2%
Precigen, Inc. (XON:NASDAQ), 293.2%
Taubman Centers, Inc. (TCO:NYSE), 53.22%
vTv Therapeutics Inc. (VTVT:NASDAQ), 52.38%
Youdao, Inc. (DAO:NYSE), 39.48%
Kezar Life Sciences, Inc. (KZR:NASDAQ), 34.58%
Co-Diagnostics, Inc. (CODX:NASDAQ), 32%
Advaxis, Inc. (ADXS:NASDAQ), 28.71%
Edgewell Personal Care Company (EPC:NYSE), 27.53%